To set up a bank of prospectively collected blood samples for pharmacokinetic analyses of monoclonal antibodies and immunophenotyping
ID
Bron
Verkorte titel
Aandoening
All malignancies that are treated with intravenous monoclonal antibodies
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
To set up a bank of prospectively collected blood samples from patients treated with monoclonal antibodies.
Achtergrond van het onderzoek
To set up a bank of prospectively collected blood samples for pharmacokinetic analyses of monoclonal antibodies and immunophenotyping
Doel van het onderzoek
To set up a bank of prospectively collected blood samples for pharmacokinetic analyses of monoclonal antibodies and immunophenotyping
Onderzoeksopzet
Prior to every infusion.
Onderzoeksproduct en/of interventie
None
Algemeen / deelnemers
Wetenschappers
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
• Age ≥18 years
• Able to understand the written information and able to give informed consent
• Planned treatment with (intravenous) monoclonal antibodies for any type of cancer according to standard of care. Monoclonal antibodies include, but are not limited to: cetuximab, nivolumab, ipilimumab, pembrolizumab, bevacizumab, and trastuzumab.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
A potential subject who meets any of the following criteria will be excluded from participation in this study:
• Unable to draw blood for study purposes
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL6828 |
| NTR-old | NTR7015 |
| Ander register | : MEC 16-011 |